Extension Study for 43USSA1705

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

December 3, 2019

Primary Completion Date

January 29, 2021

Study Completion Date

January 29, 2021

Conditions
Nasolabial Folds
Interventions
DEVICE

Sculptra Aesthetic, Lidocaine HCL

No intervention was administered during this extension study.

Trial Locations (4)

34209

Galderma Study Site, Bradenton

77388

Galderma Study Site, Spring

78746

Galderma Study Site, Austin

85255

Galderma Study Site, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT04225273 - Extension Study for 43USSA1705 | Biotech Hunter | Biotech Hunter